Notice of fundraising

2025/04/17

PeptiStar Inc. (Head Office: Settsu-shi, Osaka; President & CEO: Shinichiro Fujiie;
hereinafter “PeptiStar”) is pleased to announce that it has completed a third-party
allotment of shares with the Development Bank of Japan Inc. (Head Office: Chiyoda-ku,
Tokyo; President & CEO: Seiji Jige; hereinafter “DBJ”) as the allottee.

DBJ is a government-affiliated financial institution with the mission of "Designing the
Future with Financial Expertise." It aims to realize a sustainable society by addressing
social issues and advancing industrial development in Japan. Through collaboration
with diverse stakeholders, DBJ offers a range of solutions that include advisory,
knowledge, and asset management, and providing integrated investment and loan
services that flexibly meet the needs of its customers.

As a CDMO (Contract Development and Manufacturing Organization) specializing in
peptide and oligonucleotide therapeutics, PeptiStar provides high-quality and highly
reliable manufacturing services to clients both in Japan and internationally. Through this
capital funding, PeptiStar intends to utilize DBJ’s broad network and varied financial
services. This investment will enable us to further advance the development of innovative
products and technologies, strengthen our global capabilities, and contribute to the
pharmaceutical industry by supporting the rapid development and stable supply of new
drugs.

Going forward, we will continue to deepen our collaboration with DBJ, enhance our value
as a Japan origin CDMO, and take on new challenges to meet the evolving needs of global
healthcare.